Global Biologic Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Biologic Therapeutics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Biologic Therapeutics by Type
- 1.3.1 Overview: Global Biologic Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Biologic Therapeutics Consumption Value Market Share by Type in 2023
- 1.3.3 Vaccines
- 1.3.4 Blood Products
- 1.3.5 Allergenic Extracts
- 1.3.6 Human Cells and Tissues
- 1.3.7 Gene Therapies
- 1.3.8 Protein
- 1.3.9 Cellular Therapies
- 1.3.10 Xenotransplantation Products
- 1.4 Global Biologic Therapeutics Market by Application
- 1.4.1 Overview: Global Biologic Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Rheumatoid Arthritis
- 1.4.3 Anemia
- 1.4.4 Cancer
- 1.4.5 Diabetes
- 1.4.6 Others
- 1.5 Global Biologic Therapeutics Market Size & Forecast
- 1.6 Global Biologic Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Biologic Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Biologic Therapeutics Market Size by Region, (2019-2030)
- 1.6.3 North America Biologic Therapeutics Market Size and Prospect (2019-2030)
- 1.6.4 Europe Biologic Therapeutics Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Biologic Therapeutics Market Size and Prospect (2019-2030)
- 1.6.6 South America Biologic Therapeutics Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Biologic Therapeutics Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Biologic Therapeutics Product and Solutions
- 2.1.4 Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Pfizer Recent Developments and Future Plans
- 2.2 Novartis Global
- 2.2.1 Novartis Global Details
- 2.2.2 Novartis Global Major Business
- 2.2.3 Novartis Global Biologic Therapeutics Product and Solutions
- 2.2.4 Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Novartis Global Recent Developments and Future Plans
- 2.3 AstraZeneca
- 2.3.1 AstraZeneca Details
- 2.3.2 AstraZeneca Major Business
- 2.3.3 AstraZeneca Biologic Therapeutics Product and Solutions
- 2.3.4 AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 AstraZeneca Recent Developments and Future Plans
- 2.4 Merck
- 2.4.1 Merck Details
- 2.4.2 Merck Major Business
- 2.4.3 Merck Biologic Therapeutics Product and Solutions
- 2.4.4 Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Merck Recent Developments and Future Plans
- 2.5 GlaxoSmithKline
- 2.5.1 GlaxoSmithKline Details
- 2.5.2 GlaxoSmithKline Major Business
- 2.5.3 GlaxoSmithKline Biologic Therapeutics Product and Solutions
- 2.5.4 GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 GlaxoSmithKline Recent Developments and Future Plans
- 2.6 Aurobindo Pharma
- 2.6.1 Aurobindo Pharma Details
- 2.6.2 Aurobindo Pharma Major Business
- 2.6.3 Aurobindo Pharma Biologic Therapeutics Product and Solutions
- 2.6.4 Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Aurobindo Pharma Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Biologic Therapeutics Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Biologic Therapeutics by Company Revenue
- 3.2.2 Top 3 Biologic Therapeutics Players Market Share in 2023
- 3.2.3 Top 6 Biologic Therapeutics Players Market Share in 2023
- 3.3 Biologic Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Biologic Therapeutics Market: Region Footprint
- 3.3.2 Biologic Therapeutics Market: Company Product Type Footprint
- 3.3.3 Biologic Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Biologic Therapeutics Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Biologic Therapeutics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Biologic Therapeutics Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Biologic Therapeutics Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Biologic Therapeutics Consumption Value by Type (2019-2030)
- 6.2 North America Biologic Therapeutics Consumption Value by Application (2019-2030)
- 6.3 North America Biologic Therapeutics Market Size by Country
- 6.3.1 North America Biologic Therapeutics Consumption Value by Country (2019-2030)
- 6.3.2 United States Biologic Therapeutics Market Size and Forecast (2019-2030)
- 6.3.3 Canada Biologic Therapeutics Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Biologic Therapeutics Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Biologic Therapeutics Consumption Value by Type (2019-2030)
- 7.2 Europe Biologic Therapeutics Consumption Value by Application (2019-2030)
- 7.3 Europe Biologic Therapeutics Market Size by Country
- 7.3.1 Europe Biologic Therapeutics Consumption Value by Country (2019-2030)
- 7.3.2 Germany Biologic Therapeutics Market Size and Forecast (2019-2030)
- 7.3.3 France Biologic Therapeutics Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Biologic Therapeutics Market Size and Forecast (2019-2030)
- 7.3.5 Russia Biologic Therapeutics Market Size and Forecast (2019-2030)
- 7.3.6 Italy Biologic Therapeutics Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Biologic Therapeutics Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Biologic Therapeutics Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Biologic Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Biologic Therapeutics Consumption Value by Region (2019-2030)
- 8.3.2 China Biologic Therapeutics Market Size and Forecast (2019-2030)
- 8.3.3 Japan Biologic Therapeutics Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Biologic Therapeutics Market Size and Forecast (2019-2030)
- 8.3.5 India Biologic Therapeutics Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Biologic Therapeutics Market Size and Forecast (2019-2030)
- 8.3.7 Australia Biologic Therapeutics Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Biologic Therapeutics Consumption Value by Type (2019-2030)
- 9.2 South America Biologic Therapeutics Consumption Value by Application (2019-2030)
- 9.3 South America Biologic Therapeutics Market Size by Country
- 9.3.1 South America Biologic Therapeutics Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Biologic Therapeutics Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Biologic Therapeutics Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Biologic Therapeutics Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Biologic Therapeutics Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Biologic Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Biologic Therapeutics Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Biologic Therapeutics Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Biologic Therapeutics Market Size and Forecast (2019-2030)
- 10.3.4 UAE Biologic Therapeutics Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Biologic Therapeutics Market Drivers
- 11.2 Biologic Therapeutics Market Restraints
- 11.3 Biologic Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Biologic Therapeutics Industry Chain
- 12.2 Biologic Therapeutics Upstream Analysis
- 12.3 Biologic Therapeutics Midstream Analysis
- 12.4 Biologic Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Biologic Therapeutics market size was valued at USD 455150 million in 2023 and is forecast to a readjusted size of USD 843650 million by 2030 with a CAGR of 9.2% during review period.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biologic Therapeutics industry chain, the market status of Rheumatoid Arthritis (Vaccines, Blood Products), Anemia (Vaccines, Blood Products), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologic Therapeutics.
Regionally, the report analyzes the Biologic Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologic Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologic Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologic Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Vaccines, Blood Products).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologic Therapeutics market.
Regional Analysis: The report involves examining the Biologic Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologic Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologic Therapeutics:
Company Analysis: Report covers individual Biologic Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologic Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Rheumatoid Arthritis, Anemia).
Technology Analysis: Report covers specific technologies relevant to Biologic Therapeutics. It assesses the current state, advancements, and potential future developments in Biologic Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologic Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biologic Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Market segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Market segment by players, this report covers
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biologic Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologic Therapeutics, with revenue, gross margin and global market share of Biologic Therapeutics from 2019 to 2024.
Chapter 3, the Biologic Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biologic Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Therapeutics.
Chapter 13, to describe Biologic Therapeutics research findings and conclusion.